Shannon Gallagher

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes

J. Lancaster, A. Gutin, J. Garber, 2020, JAMA network open.

Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.

K. Baggerly, T. Conrads, A. Sood, 2021, Gynecologic oncology.

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model

A. Gutin, J. Garber, M. Robson, 2021, JCO precision oncology.

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk

J. Lancaster, A. Gutin, J. Garber, 2020, JCO precision oncology.

77 An NGS assay to identify HLA loss of heterozygosity for future CEA and MSLN logic-gated CAR-T solid tumor protocols designed for reduced on-target, off-tumor toxicity

D. Maloney, M. Borad, S. Kopetz, 2022, Regular and Young Investigator Award Abstracts.

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing

J. Lancaster, C. Adami, A. Gutin, 2021, JCO precision oncology.

Discovering disease-causing pathogens in resource-scarce Southeast Asia using a global metagenomic pathogen monitoring system

Katrina L Kalantar, N. Neff, J. Derisi, 2021, medRxiv.